搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
4 天
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...
health enews
7 天
Nasal congestion on one side? You may have this condition
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
Onlymyhealth
9 天
From Allergies to Asthma, These Conditions Can Trigger Nasal Polyps
often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...
12 小时
Scientists Have Pushed the Schrödinger’s Cat Paradox to New Limits
A research team in China has held atoms in a state of quantum superposition for 23 minutes, suggesting tantalizing new ...
12 天
Nose strips vs nasal clippers: The better way to control snoring is…
Snoring is caused when airflow through the mouth and nose gets partially blocked during sleep. This can happen due to various ...
Monthly Prescribing Reference
6 天
Tezepelumab Reduces Nasal Congestion and Polyp Size in Chronic Rhinosinusitis
Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...
6 天
on MSN
FDA proposes ending use of popular decongestant in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
Woman's World on MSN
6 天
Is Your Toothache Actually a Sinus Infection? How to Tell—and Treat It
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
6 天
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
4 天
on MSN
What is oral phynylephrine and why does the FDA want to remove it from cold medicine?
Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common ...
Reuters on MSN
6 天
U.S. FDA proposes ending use of popular decongestant present in cold medicines
It is also an ingredient in nasal sprays to treat congestion. However, the FDA's action is only related to orally ...
FiercePharma
5 天
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈